1. Home
  2. VRA vs NTHI Comparison

VRA vs NTHI Comparison

Compare VRA & NTHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Vera Bradley Inc.

VRA

Vera Bradley Inc.

HOLD

Current Price

$3.10

Market Cap

117.4M

ML Signal

HOLD

NTHI

NeOnc Technologies Holdings Inc.

HOLD

Current Price

$4.68

Market Cap

139.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VRA
NTHI
Founded
1982
2008
Country
United States
United States
Employees
N/A
5
Industry
Apparel
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
117.4M
139.1M
IPO Year
2010
N/A

Fundamental Metrics

Financial Performance
Metric
VRA
NTHI
Price
$3.10
$4.68
Analyst Decision
Hold
Strong Buy
Analyst Count
2
1
Target Price
N/A
$15.00
AVG Volume (30 Days)
119.2K
66.7K
Earning Date
06-10-2026
05-19-2026
Dividend Yield
N/A
N/A
EPS Growth
20.47
N/A
EPS
N/A
N/A
Revenue
$416,097,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$2.50
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.39
$3.20
52 Week High
$4.39
$12.99

Technical Indicators

Market Signals
Indicator
VRA
NTHI
Relative Strength Index (RSI) 38.33 45.06
Support Level $3.03 $4.49
Resistance Level $3.39 $5.90
Average True Range (ATR) 0.20 0.41
MACD -0.02 -0.03
Stochastic Oscillator 21.57 37.93

Price Performance

Historical Comparison
VRA
NTHI

About VRA Vera Bradley Inc.

Vera Bradley Inc designs women's handbags, luggage, and travel items, fashion and home accessories, and gifts. Each category comprises a substantial component of total sales, with the bags category comprising the majority of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct and Vera Bradley Indirect.

About NTHI NeOnc Technologies Holdings Inc.

NeOnc Technologies Holdings Inc. is a clinical-stage biopharmaceutical company focused on developing novel molecular technologies for the targeted delivery of therapeutics to treat central nervous system diseases. The company is developing drug delivery methods and drug candidates for intracranial malignancies such as gliomas, glioblastoma, and meningioma. Its lead product candidates include NEO100, an intranasal drug delivery therapy for brain cancer patients, and NEO212, an oral chemical conjugate designed to enhance treatment for glioblastoma.

Share on Social Networks: